Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-26-034158
Filing Date
2026-03-25
Accepted
2026-03-25 08:01:55
Documents
2
Period of Report
2026-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm269800d1_6k.htm 6-K 11192
2 EXHIBIT 99.1 tm269800d1_ex99-1.htm EX-99.1 13797
  Complete submission text file 0001104659-26-034158.txt   26062
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 26788417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)